Clinical effects of wasabi extract containing 6-MSITC on myalgic encephalomyelitis/chronic fatigue syndrome: an open-label trial

Table 3 Changes in fatigue-related indices after 6-MSITC treatment

	Descriptive	Pre	Post	Δ	P	ES
CFS-11	Physical	13.9 ± 4.2	14.1 ± 3.3	0.2 ± 5.2	0.884	-0.038
	Mental	8.1 ± 3.9	6.4 ± 1.8	-1.7 ± 3.2	0.063	0.521
	Total	22.0 ± 6.2	20.5 ± 4.5	-1.5 ± 5.7	0.339	0.255
Fatigue	Severity	5.9 ± 2.3	5.5 ± 2.6	-0.4 ± 1.1	0.150	0.393

Δ: differences between scores before and after treatment (subtraction of Pre from Post), ES: effect sizes were calculated using the Cohen’s d. P: p values were analyzed using a parametric paired Student’s t-test. Severity was described using a numerical rating scale, with 10 being the worst and 0 being none. CFS-11 11-item Chalder Fatigue Scale; (n = 15)

ISSN: 1751-0759